Prevalence, Awareness and Management of Hypertension in Acute Care Personnel
NCT ID: NCT01655654
Last Updated: 2020-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
160 participants
INTERVENTIONAL
2012-08-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hypertension Prevention Program, Implementation and Scale up- a Hybrid Effectiveness Implementation Study
NCT04899648
Improving Practice Patterns for the Treatment of Hypertension
NCT00265044
PRESSURE CHECK: Find Your Path to Better Health
NCT06122246
Remote Monitoring and Social Support for Hypertension Management
NCT03416283
Fight Hypertension in the Digital Age
NCT03659656
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary purpose of this study is to quantify differences in HTN prevalence, awareness and management in three distinctly different areas and shifts within an acute hospital. Blood pressure (BP) will be taken during working hours along with pre and post sleep hours. The secondary purpose is to identify the effect of shift work within an acute care hospital and effectiveness of: BP monitoring, increases in physical activity, positive nutritional changes, and the correlation between a primary care provider visits and lowering BP.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort 1
All employees within the acute care hospital that signed the informed consent form and provided their individual data.
No interventions assigned to this group
Cohort 2
All subjects of cohort 1 who also are considered hypertensive and participated in one or more study interventions, which include behavioral interventions (an increase in physical activity, or dietary changes) or who have a primary care provider visit to discuss hypertension.
Physical activity
This intervention includes cardiorespiratory exercise, resistance exercise, flexibility exercise and neuromotor exercise.
Dietary
Make at least one positive dietary change including or similar to a DASH diet snack substitution.
Primary care provider visit
Subjects with hypertension will be asked to visit their primary care provider seeking treatment options. If a subject does not have a primary care provider then they will be encouraged to obtain one and seek medical treatment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical activity
This intervention includes cardiorespiratory exercise, resistance exercise, flexibility exercise and neuromotor exercise.
Dietary
Make at least one positive dietary change including or similar to a DASH diet snack substitution.
Primary care provider visit
Subjects with hypertension will be asked to visit their primary care provider seeking treatment options. If a subject does not have a primary care provider then they will be encouraged to obtain one and seek medical treatment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects who will be included in the intervention part of the study will have two consecutive BP readings of \> 140/90
* Has or is willing to have collaborative PCP
* Understand and sign the informed consent form
Exclusion Criteria
* Has a severe systemic illness with life expectancy judged less than three years
* Has a severe vascular event such as Myocardial Infarction or Cerebral Vascular Event in the past 90 days
* Is enrolled in another therapeutic program or similar study, and
* Has a condition which, in the opinion of the investigators, may prevent the subject from participating in the study
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Providence Health & Services
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dan Donahue, M.Ed.
Role: PRINCIPAL_INVESTIGATOR
Providence Health and Services
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Providence St. Peter Hospital
Olympia, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PSWR-002-EHW
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.